Profile
Profile
- Corporate Name
- Alfresa Pharma Corporation
- Address
- Headquarters:
2-2-9 Kokumachi, Chuo-ku, Osaka 540-8575, Japan
TEL. +81-6-6941-0300 FAX. +81-6-6947-1548
- Incorporation
- December 24, 1939
- Capital
- 3 billion yen
- President&CEO
- Katsutoshi Araki
- Number of Employees
- 1,408 employees (as of April 1, 2025)
- Description of Business
- Manufacture, import, export and marketing of pharmaceuticals, diagnostic products, medical devices, pharmaceutical raw materials, etc.
- Banks
- MUFG Bank, Ltd.
History
Alfresa Pharma Corporation
- 1920:
- Nakashima Shigeru Shoten is founded as an importer and distributor of pharmaceuticals and medical devices in Manila, the Republic of Philippines.
- 1939:
- Incorporates Osaka Office into Nakashima Shigeru Shoten.
- 1952:
- Corporate name changes to Nippon Shoji Kaisha, Ltd.
- 1998:
- Nippon Shoji and Showa Pharmaceuticals merge to form AZWELL Inc.
- 2003:
- AZWELL Inc. and Fukujin Co., Ltd. establish Alfresa Holdings Corporation through stock transfer.
- 2004:
- Alfresa Pharma Corporation is created.
- 2006:
- Ibaraki Research Center, Okayama Plant, and Chiba Plant obtain the ISO13485:2003 certification.
- 2015:
- Takes over the Akita Plant of Daiichi Sankyo Propharma Co., Ltd., and establishes Alfresa Fine Chemical Corporation.
Sannova Co., Ltd.
- 1923:
- Started business as a pharmaceuticals developer and manufacturer under the name of Sansho Co., Ltd.
- 1933:
- The business expanded due to the success of the liver oil tablet, "Haliva."
- 1965:
- started full-scale production of pharmaceuticals for Eisai Co., Ltd.
- 1968:
- Became a subsidiary of Eisai Co., Ltd.
- 1986:
- Eisai Co., Ltd. released the medicine for iron-deficiency, anemia, developed by ourself.
- 1989:
- Acquired an authorization of contract manufacturing from Eisai Co., Ltd.
- 1996:
- Transitioned into a large company under commercial law based on increased capital.
- 1997:
- Started production of barrier-free medicines, marketed by Elmed Eisai Co., Ltd.
Acquired a manufacturing authorization of liquid-, ointment-, and cream-form medicines from Eisai Co., Ltd.
- 1998:
- Relocated the headquarters to Serada-Cho, Ota City, Gunma (previously known as Ojima-machi, Nitta-gun).
- 1999:
- Completed relocation of whole company to Serada-Cho, Ota City, Gunma.
Changed the corporate name to Sannova Co., Ltd.
- 2001:
- Obtained the ISO 14001 certification.
- 2004:
- Established new drainage treatment facilities.
- 2016:
- Sannova Co., Ltd. became a wholly owned subsidiary of Alfresa Holdings Corporation.
- 2023:
- Alfresa Pharma Corporation and Sannova Co., Ltd. merges their operations.
Group Companies
Alfresa Pharma is a member of the Alfresa family of companies. For more on our group philosophy, mission and vision, please visit the website of Alfresa Holdings at http://www.alfresa.com/eng/index.html